GAMMA Investing’s Moderna MRNA Stock Holding History

GAMMA Investing’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.01M	Sell	14,479 -818	-5%	-$42.3K	0.04%	397
2026 Q1	$777K	Buy	15,297 +5,062	+49%	+$236K	0.04%	421
2025 Q4	$302K	Sell	10,235 -172	-2%	-$4.67K	0.02%	763
2025 Q3	$269K	Buy	10,407 +1,261	+14%	+$35.2K	0.01%	794
2025 Q2	$252K	Buy	9,146 +1,220	+15%	+$32.1K	0.02%	764
2025 Q1	$225K	Buy	7,926 +4,753	+150%	+$169K	0.02%	710
2024 Q4	$132K	Buy	3,173 +768	+32%	+$36.7K	0.01%	923
2024 Q3	$161K	Sell	2,405 -1,935	-45%	-$178K	0.02%	722
2024 Q2	$515K	Buy	4,340 +1,346	+45%	+$170K	0.07%	259
2024 Q1	$319K	Buy	2,994 +822	+38%	+$82.9K	0.07%	283
2023 Q4	$219K	Buy	+2,172	New	+$183K	0.06%	290

Other funds holding MRNA

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

GAMMA Investing's MRNA Position: Q2 2026 in Review

GAMMA Investing reduced its Moderna (MRNA) stake by 5.3% in Q2 2026, selling an estimated $42.3K and leaving 14,479 shares worth $1.01M. The position accounts for 0.04% of the portfolio, ranked #397.

GAMMA Investing first reported a position in MRNA in Q4 2023 and has held it in 11 quarters since. 183 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

GAMMA Investing held 14,479 shares of Moderna worth $1.01M as of Q2 2026.
GAMMA Investing sold 818 Moderna shares in Q2 2026, an estimated $42.3K.
Moderna made up 0.04% of GAMMA Investing's portfolio in Q2 2026, its #397 holding.
GAMMA Investing first reported a position in Moderna in Q4 2023 and has held it in 11 quarters since.
183 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.